Vaccine Design and Testing – News and Features

The pathogen that causes sepsis has thwarted vaccines, but researchers now know why.

A bacterium that exists on the skin of nearly everyone on Earth could be transformed into a topical vaccine.

Researchers find answers to why older people had a somewhat reduced immune response to the mRNA vaccines administered during the COVID-19 pandemic when compared with younger adults.

Two bacterial strains may be linked to higher rates of colon cancer in some countries. This may provide a target for the development of measures such as vaccines to cut rates of colon cancer.

This article explores the latest techniques and workflows for purification across biopharmaceuticals including vaccines, monoclonal antibody therapies and gene therapies.

As the field of oligonucleotide therapeutics continues to evolve, the integration of robust analytical tools will be essential in advancing personalized medicine and improving patient outcomes across a wide range of diseases.

A new study has uncovered how "Conan the Bacterium" can withstand radiation doses thousands of times higher than would kill a human.

Researchers have uncovered a molecular strategy employed by worm parasites to evade host immune defenses, opening new avenues for the development of innovative vaccines.

Researchers have identified that the SARS-CoV-2 spike protein accumulates in the brain's protective layers, potentially explaining the neurological symptoms of long COVID.

A study from MUSC Hollings Cancer Center shows a 62% drop in cervical cancer deaths among women under 25, attributed to HPV vaccination. Despite this success, HPV vaccination rates remain below target, with only 60% of adolescents vaccinated.